Heart Defect Closure Device Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

How Will the Heart Defect Closure Device Market Grow, and What Is the Projected Market Size?
The market size for heart defect closure devices has experienced a swift expansion in the past few years. It is projected to surge from $1.11 billion in 2024 to $1.27 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.5%. The significant increment during the historical period can be linked to an increased count of individuals with inborn heart conditions, an aging society, heightened health consciousness, a rise in research and development, and the progression of catheterization methods.

Rapid expansion is projected for the heart defect closure device market in the upcoming years, with an expected valuation of $2.17 billion by 2029, reflecting a compound annual growth rate (CAGR) of 14.2%. This progression throughout the forecast period is due to an increase in congenital defects, enhancement in diagnostic methods, preferment of MRI procedures, usage growth of 3d imaging during heart defect closure processes, and the higher prevalence of ischemic stroke. The forecast period will also witness key trends including technological progress, creation of cutting-edge products, generation of advanced heart closure devices, the rising discovery of PFO closure devices, plus the crucial need to evaluate the benefits of PFO closure within the elderly populace.

What Factors Are Fueling Growth in the Heart Defect Closure Device Market?
The heart defect closure device market is set for expansion, driven by the increasing population of individuals suffering from congenital heart problems. This refers to heart structure anomalies that individuals are born with, caused by various factors such as genetic predilections, environmental effects, and maternal health issues like diabetes, obesity, or exposure to certain medications or infections during pregnancy. Abnormal heart openings can be sealed using heart defect closure devices, which offer non-invasive solutions, reinstate regular blood circulation, diminish potential complications, and enhance overall heart performance. For instance, the National Library of Medicine (NLM), renowned for its research in biomedical informatics and computational health data science in the U.S, in their October 2024 publication, documented a steep rise in Congenital Heart Disease (CHD) incidence rates: a leap to 5.46% in 2023, from 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022. Consequently, the swelling population of people with congenital heart anomalies is propelling the heart defect closure device market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp

Who Are the Major Industry Players Fueling Heart Defect Closure Device Market Expansion?
Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and Associates, B. Braun, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Baylis Medical Company Inc., Biosense Webster Inc., Sahajanand Medical Technologies Limited, Occlutech, coherex* Medical Inc., Cardia Inc., Acrostak Corporation, Vivasure Medical, Transmural Systems Inc., Cormatrix Cardiovascular Inc., and St. Jude Medical LLC.

Which Key Developments Are Influencing the Heart Defect Closure Device Market?
Leading players in the heart defect closure device market are progressing towards the creation of self-expanding, double-disc occluders. These devices offer a less invasive method for solving heart defects, enhancing the security of the procedure, improving patient recovery times, and reducing the probability of complications related to conventional open-heart surgeries. For example, in September 2022, US-based medical and health care firm Abbott Laboratories launched the Amplatzer Talisman PFO Occlusion System in Europe. This medical device is specifically engineered to close a patent foramen ovale (PFO), an unusual gap present between the left and right atria of the heart, which can result in strokes and various other complications. The system employs a minimally invasive process to position a self-expanding, double-disc occluder made out of nitinol wire mesh, effectively clotting the PFO and hampering the movement of clots between the atria.

How Is the Segmentation of the Heart Defect Closure Device Market Defined?
The heart defect closure device market covered in this report is segmented -

1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices
2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders
4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders
5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

What Is the Leading Region in the Heart Defect Closure Device Market?
North America was the largest region in the heart defect closure device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Heart Defect Closure Device Global Market Report?

- Market Size Analysis: Analyze the Heart Defect Closure Device Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Heart Defect Closure Device Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Heart Defect Closure Device Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Heart Defect Closure Device Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16074

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.